The Bladder Instillation Comparison Study
NCT02695771
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
101
Enrollment
OTHER
Sponsor class
Conditions
Urinary Bladder Neoplasms
Interventions
DRUG:
Mitomycin C
DRUG:
Gemcitabine
Sponsor
Corewell Health West